Prelude Capital Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-869
Closed -$23K 2214
2020
Q2
$23K Buy
869
+796
+1,090% +$19.8K ﹤0.01% 1353
2020
Q1
$2K Sell
73
-322
-82% -$7.87K ﹤0.01% 1316
2019
Q4
$10K Buy
+395
New +$9.17K ﹤0.01% 1704
2018
Q4
Sell
-315
Closed -$14K 2066
2018
Q3
$14K Buy
+315
New +$14.9K ﹤0.01% 1393
2018
Q2
Sell
-202
Closed -$8K 1869
2018
Q1
$8K Buy
+202
New +$7.48K ﹤0.01% 1379
2017
Q4
Sell
-8,100
Closed -$300K 1614
2017
Q3
$300K Buy
8,100
+4,200
+108% +$158K 0.03% 519
2017
Q2
$144K Sell
3,900
-17,577
-82% -$574K 0.01% 677
2017
Q1
$604K Buy
21,477
+12,695
+145% +$358K 0.06% 314
2016
Q4
$257K Buy
+8,782
New +$240K 0.03% 486
2016
Q3
Sell
-14,056
Closed -$262K 1754
2016
Q2
$262K Buy
14,056
+12,356
+727% +$258K 0.04% 421
2016
Q1
$46K Hold
1,700
0.01% 988
2015
Q4
$51K Hold
1,700
0.01% 1042
2015
Q3
$54K Hold
1,700
0.01% 1041
2015
Q2
$66K Buy
+1,700
New +$58.6K 0.01% 1052
2014
Q4
Sell
-2,345
Closed -$53K 2099
2014
Q3
$53K Buy
+2,345
New +$47K 0.01% 1377

Other funds holding PAHC

Prelude Capital Management's PAHC Position: Q3 2020 in Review

Prelude Capital Management sold out of Phibro Animal Health (PAHC) in Q3 2020, closing a stake of 869 shares — an estimated $23K sold.

Prelude Capital Management first reported a position in PAHC in Q3 2014 and held it in 15 quarters. The position peaked at $604K in Q1 2017. 136 funds tracked by Wall St. Rank hold PAHC as of Q3 2020.

  • Prelude Capital Management reported no remaining Phibro Animal Health position as of Q3 2020 after selling out during the quarter.
  • Prelude Capital Management sold 869 Phibro Animal Health shares in Q3 2020, an estimated $23K.
  • Prelude Capital Management first reported a position in Phibro Animal Health in Q3 2014 and held it in 15 quarters.
  • Prelude Capital Management's Phibro Animal Health position peaked at $604K in Q1 2017.
  • 136 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2020.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.